Skip to main content
Livermore
Livermore
ZHEN

Davis Selected Advisers

SEC CIK
0001036325
Latest filing
Aug 11, 2026

DGX holding history

Quest Diagnostics Inc in every 13F filed by Davis Selected Advisers, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DGX overviewAll 13F holders of DGXFull Q2 2026 holdings

Shares (Q2 2026)
1,555,612
Value
$329.8M
% of portfolio
1.4%
Quarters held
22
Since Q1 2021
Holdings of DGX by Davis Selected Advisers, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,555,612$329.8M1.4%−62,201−3.8%ReducedHolders
Q1 20261,617,813$317.1M1.5%+27,930+1.8%AddedHolders
Q4 20251,589,883$275.9M1.2%+228,271+16.8%AddedHolders
Q3 20251,361,612$259.5M1.4%+7,192+0.5%AddedHolders
Q2 20251,354,420$243.3M1.3%−1,033,882−43.3%ReducedHolders
Q1 20252,388,302$404.1M2.3%−8,958−0.4%ReducedHolders
Q4 20242,397,260$361.7M2.1%−1,843−0.1%ReducedHolders
Q3 20242,399,103$372.5M2.1%+8,275+0.3%AddedHolders
Q2 20242,390,828$327.3M1.9%+9,665+0.4%AddedHolders
Q1 20242,381,163$317.0M1.8%−285,401−10.7%ReducedHolders
Q4 20232,666,564$367.7M2.1%+998,866+59.9%AddedHolders
Q3 20231,667,698$203.2M1.3%+153,810+10.2%AddedHolders
Q2 20231,513,888$212.8M1.3%−4,864−0.3%ReducedHolders
Q1 20231,518,752$214.9M1.4%−317,071−17.3%ReducedHolders
Q4 20221,835,823$287.2M2.0%−35,337−1.9%ReducedHolders
Q3 20221,871,160$229.6M1.6%−18,655−1.0%ReducedHolders
Q2 20221,889,815$251.3M1.6%−57,243−2.9%ReducedHolders
Q1 20221,947,058$266.5M1.3%−59,570−3.0%ReducedHolders
Q4 20212,006,628$347.2M1.6%−736,328−26.8%ReducedHolders
Q3 20212,742,956$398.6M1.8%−72,658−2.6%ReducedHolders
Q2 20212,815,614$371.6M1.5%+37,508+1.4%AddedHolders
Q1 20212,778,106$356.5M1.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.